![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » UK Lines Up COVID-19 Vaccine Supply Deals With Novavax, J&J
UK Lines Up COVID-19 Vaccine Supply Deals With Novavax, J&J
![Vaccine needle](https://www.fdanews.com/ext/resources/test/Drug-Images4/Vaccine-needle-bottle.gif?t=1596243581&width=430)
The UK government is set to purchase 90 million COVID-19 vaccine doses from Novavax and Johnson & Johnson.
Under the agreements, the government will purchase 60 million doses of Novavax’s NVX-CoV2373 and 30 million doses of J&J’s Ad26.COV2.S. The deal with J&J includes an option to purchase an additional 22 million doses.
The UK government will also support a phase 3 trial of Novavax’s NVX-CoV2373 in the UK and a separate, long-term global phase 3 trial of J&J’s Ad26.COV2.S.
Upcoming Events
-
21Oct